| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |